Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVAIR vs Usual Care in Asthma
NCT00273026Phase 4Terminated
- Sponsor
- GSK
- Start
- Nov 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluticasone propionate in asthma (2 arms), sponsored by GSK. Primary endpoint: Percentage of patients achieving well-controlled asthma at 24 weeks. Started Nov 2004; status: terminated.
02
Drugs
fluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00273026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273026.